SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatkin Jones Regulatory News (WJG)

Share Price Information for Watkin Jones (WJG)

Share Price is delayed by 15 minutes
Get Live Data
19.50    0.00 (0.00%)
Bid:
20.00
Ask:
20.30
Spread: 0.30 (1.50%)
Market Cap: £50.09m
WJG Live PriceLast checked at - London Stock Exchange

Intraday Watkin Jones Share Chart

Director/PDMR Shareholding

15 Mar 2024 15:42

RNS Number : 1115H
Watkin Jones plc
15 March 2024
 

For immediate release

15 March 2024

 

Watkin Jones plc

('Watkin Jones' or the 'Company')

 

 

Issue of Equity

Director/PDMR Shareholding

 

Watkin Jones plc (AIM: WJG) announces that it has issued and allotted 211,844 ordinary shares of 1 penny each in the Company ("Ordinary Shares") pursuant to the exercise of awards under the Company's Deferred Share Bonus Plan ("DSBP").

 

Accordingly, application has been made for the 211,844 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective, and that dealings will commence in the new Ordinary Shares at 08.00 a.m. on 18 March 2024. The new Ordinary Shares will rank, pari passu, with the existing Ordinary Shares.

 

In order to meet the costs of the exercise, and the personal taxation liabilities arising on the exercise, Sarah Sergeant, Chief Financial Officer of the Company, has sold, in aggregate, 44,153 Ordinary Shares, each at a price of 42.66p per Ordinary Share, which is set out in the table below. The balance of the new Ordinary Shares have been retained by Sarah Sergeant.

Name

Role

Number of Ordinary Shares exercised

Number of Ordinary Shares sold

Resulting interest in Ordinary Shares

Resulting percentage of Ordinary Shares

Sarah Sergeant

Chief Financial Officer

90,765

44,153

76,562

0.03%

 

Total Voting Rights

 

Following Admission, the Company's total issued share capital will comprise 256,653,097 Ordinary Shares. The Company does not hold any shares in treasury. Therefore the total number of voting rights in the Company will be 256,653,097. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of interest in, the share capital of the Company under the FCA's Disclosure, Guidance and Transparency Rules.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Sarah Sergeant

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Watkin Jones plc

 

b)

LEI

2138009X19O21NU5SG79

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of £0.01 each

 

 

ISIN: GB00BD6RF223

b)

Nature of the transaction

Exercise of award under the DBSP

c)

Price(s) and volume(s)

Price

No. of shares

1p

90,765

d)

Aggregated information

- Aggregated volume

- Price

 

 

n/a

 

e)

Date of the transaction

15 March 2024

f)

Place of the transaction

Outside of a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Sarah Sergeant

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Watkin Jones plc

 

b)

LEI

2138009X19O21NU5SG79

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of £0.01 each

 

 

ISIN: GB00BD6RF223

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price

No. of shares

42.66p

44,153

d)

Aggregated information

- Aggregated volume

- Price

 

 

n/a

 

e)

Date of the transaction

15 March 2024

f)

Place of the transaction

London Stock Exchange, AIM

 

 

- Ends -

 

For further information:

Watkin Jones plc

 

Alex Pease, Chief Executive Officer

Tel: +44 (0) 20 3617 4453

Sarah Sergeant, Chief Financial Officer

 

Peel Hunt LLP (Nominated Adviser & Joint Corporate Broker)

 

 

Tel: +44 (0) 20 7418 8900

Mike Bell / Ed Allsopp

www.peelhunt.com

 

Jefferies Hoare Govett (Joint Corporate Broker)

 

Tel: +44 (0) 20 7029 8000

James Umbers / David Sheehan / Paul Bundred

 

www.jefferies.com

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Steph Whitmore

watkinjones@buchanan.uk.com

Tel: +44 (0) 20 7466 5000

www.buchanan.uk.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQKPBQPBKDKND
Date   Source Headline
1st Jun 20267:00 amRNSChange of Registered Office
28th May 20263:00 pmRNSInvestor Presentation via Investor Meet Company
27th May 20267:00 amRNSHalf Year Results
19th May 20267:00 amRNSNotice of H1-2026 Results
1st May 20267:00 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSHY 2026 Trading Update
13th Apr 20261:50 pmRNSHolding(s) in Company
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20264:20 pmRNSHolding(s) in Company
25th Mar 20264:14 pmRNSHolding(s) in Company
11th Mar 20262:39 pmRNSHolding(s) in Company
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20262:00 pmRNSResult of AGM
3rd Feb 202611:46 amRNSBlocklisting Application
28th Jan 20261:26 pmRNSHolding(s) in Company
20th Jan 20267:00 amRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSAnnual Report and Notice of AGM
22nd Dec 20257:00 amRNSDevelopment Partnership for 294-unit hotel
22nd Dec 20257:00 amRNSDevelopment Partnership for 294-unit hotel
19th Dec 202512:02 pmRNS-RProgressive publishes new research
19th Dec 202512:02 pmRNS-RProgressive publishes new research
17th Dec 20258:17 amRNSPresentation via Investor Meet Company
16th Dec 20257:00 amRNSFull Year Results
15th Dec 20251:10 pmRNSWJ & Maslow Capital announce £102m PBSA scheme
21st Oct 20257:00 amRNSFY25 Trading Update
1st Oct 202510:44 amRNSHolding(s) in Company
30th Sep 20257:00 amRNSWatkin Jones announces £182m PBSA Joint Venture
10th Sep 20257:00 amRNSHolding(s) in Company
5th Sep 20257:00 amRNSAppointment of Joint Corporate Broker
4th Sep 202512:54 pmRNSHolding(s) in Company
12th Aug 20257:00 amRNSDevelopment Partnership for 200-unit PBSA scheme
1st Jul 20257:00 amRNSIssue of Sharesave options and PDMR shareholdings
29th May 20253:36 pmRNSPresentation via Investor Meet Company
29th May 20257:00 amRNSHalf Year Results
28th May 202511:56 amRNSHolding(s) in Company
22nd May 20257:00 amRNSNotice of H1-2025 Results
29th Apr 20257:00 amRNSHY25 Trading Update
4th Apr 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20254:12 pmRNSNotification of Major Holdings
4th Mar 20252:26 pmRNSResult of AGM
12th Feb 20252:11 pmRNSNotification of Major Holdings
7th Feb 20257:50 amRNSAnnual Report and Notice of AGM
5th Feb 20257:00 amRNSDirector/PDMR Shareholding
31st Jan 20259:53 amRNSDevelopment Partnership for 260-unit Aparthotel
27th Jan 20254:59 pmRNS-RPresentation via Investor Meet Company
27th Jan 20254:55 pmRNSPresentation via Investor Meet Company
27th Jan 20251:23 pmRNSDirector/PDMR Shareholding
23rd Jan 20257:00 amRNSFull Year Results 2024
17th Jan 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.